I'm LongbridgeAI, I can summarize articles.Catalyst Pharmaceuticals' entire board resigned and was replaced by directors from Merger Sub upon the merger's effective time. This change, resulting from the consummation of a merger agreement, involved seven outgoing directors and three incoming directors who became members of the Surviving Corporation's board.
Catalyst Pharmaceuticals saw its entire board resign and be replaced by the Merger Sub directors as of the Merger's Effective Time.
| Individual | Patrick J. McEnany | Richard J. Daly | Daniel J. Curran, M.D. | Donald A. Denkhaus | Molly Harper | Tamar Thompson | David S. Tierney, M.D. | Sergio Marullo di Condojanni | Massimo Marin | Enrica Dogali |
| Role | Director | Director | Director | Director | Director | Director | Director | Director (Merger Sub → Surviving Corporation) | Director (Merger Sub → Surviving Corporation) | Director (Merger Sub → Surviving Corporation) |
| Type of Change | Resigned | Resigned | Resigned | Resigned | Resigned | Resigned | Resigned | Appointed | Appointed | Appointed |
| Effective Date | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) | Effective Time (of Merger) |
| Reason | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) | Consummation of Merger (per Merger Agreement) |
| Replacement Info | Sergio Marullo di Condojanni and others (see columns) | Sergio Marullo di Condojanni and others (see columns) | Sergio Marullo di Condojanni and others (see columns) | Sergio Marullo di Condojanni and others (see columns) | Sergio Marullo di Condojanni and others (see columns) | Sergio Marullo di Condojanni and others (see columns) | Sergio Marullo di Condojanni and others (see columns) | N/A | N/A | N/A |
| Background Details | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Former directors of Merger Sub | Former directors of Merger Sub | Former directors of Merger Sub |
| Board/Committee Role Changes | Ceased to be directors and members of any committees | Ceased to be directors and members of any committees | Ceased to be directors and members of any committees | Ceased to be directors and members of any committees | Ceased to be directors and members of any committees | Ceased to be directors and members of any committees | Ceased to be directors and members of any committees | Became directors of the Surviving Corporation | Became directors of the Surviving Corporation | Became directors of the Surviving Corporation |
Original SEC Filing: CATALYST PHARMACEUTICALS, INC. [ CPRX ] - 8-K - Jul. 15, 2026